Bulk Inquiry
LBH 589
- NVP-LBH 589 - Panobinostat- Soluble in DMSO
- MF: C21H23N3O2
- MW: 349.43
Description
LBH 589 (Panobinostat) is a highly potent pan-HDAC inhibitor with reported subnanomolar activity against HDAC1.
Histone deacetylases regulate chromatin accessibility, transcription, cell-cycle control and apoptosis. LBH 589 is used to study epigenetic modulation, acetylation-dependent gene expression and antitumor responses in solid and hematologic cancer models.
Key Features
- Potent pan-HDAC inhibitor
- Reported HDAC1 IC50 around 0.23 nM
- Increases histone acetylation and alters transcriptional programs
- Relevant to apoptosis, differentiation and tumor growth research
Applications
- HDAC enzyme pharmacology
- Epigenetic gene-regulation studies
- Cancer cell apoptosis and differentiation assays
- Hematologic and solid tumor model research
More Information
| Parent CAS No. | 404950-80-7 |
|---|---|
| Chemical Name | (E)-N-Hydroxy-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-acrylamide |
| SMILES | N1C2C=CC=CC=2C(CCNCC2=CC=C(C=C2)/C=C/C(NO)=O)=C1C |
| MFCD | MFCD09833242 |
| InChi | InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+ |
| InChiKey | FPOHNWQLNRZRFC-ZHACJKMWSA-N |
| CID | 6918837 |
| Short Description | HDAC inhibitor |
References
- P Maiso et al. The Histone Deacetylase Inhibitor LBH589 Is a Potent Antimyeloma Agent that Overcomes Drug Resistance. Cancer Res. 2006, 66(11), 5781-5789.
- AA Lane and BA Chabner. Histone Deacetylase Inhibitors in Cancer Therapy. J. Clin. Oncol. 2009, 27(32), 5459 - 5468.
- L Ellis et al. The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy. Blood, 2009, 114(2), 380 - 393.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 4468 | Colrestat |
From $154.00 |
| 1645 | HDAC6 inhibitor ISOX |
From $121.00 |
| 1707 | MC 1568 |
From $93.50 |
| 1777 | SB 939 |
From $104.50 |
| 1801 | Pyroxamide |
From $99.00 |
| 1803 | MS 275 |
From $66.00 |
| 1853 | PCI 34051 |
From $99.00 |
| 2014 | CI 994 |
From $77.00 |
| 2180 | TMP 195 |
From $121.00 |
| 2195 | RGFP 966 |
From $93.50 |
| 2209 | Sodium butyrate |
From $55.00 |
| 2359 | Nexturastat A |
From $99.00 |
| 2394 | AR-42 |
From $137.50 |
| 2430 | LW 479 |
From $148.50 |
| 2471 | BRD 73954 |
From $93.50 |
| 2495 | Santacruzamate A |
From $93.50 |
| 2505 | Mocetinostat |
From $88.00 |
| 2518 | UF 010 |
From $66.00 |
| 2529 | JNJ 26481585 dihydrochloride |
From $137.50 |
| 2620 | Quininib |
From $104.50 |
| 2893 | Tucidinostat |
From $104.50 |
| 2996 | TH 34 |
From $132.00 |
| 3038 | CXD101 |
From $137.50 |
| 3039 | ACY-241 |
From $132.00 |


